You are here: Industry Insights > hypoglycemia

News List

FDA Approves Second Biosimilar Insulin Product, Rezvoglar (insulin glargine-aglr) AmericanPharmaceuticalReview
December 22, 2021
The Food and Drug Administration approved the second biosimilar insulin product, Eli Lilly’s Rezvoglar (insulin glargine-aglr). Rezvoglar (insulin glargine-aglr) is biosimilar to Lantus (insulin glargine).
FDA approves Zealand Pharma’s Zegalogue for hypoglycemia treatment pharmaceutical-business-review
March 24, 2021
Zealand Pharma has announced the US Food and Drug Administration (FDA) approval of its Zegalogue (dasiglucagon) injection for the treatment of patients aged six and above with severe hypoglycemia.
Xeris Receives European Commission Approval of Ogluo for Hypoglycemia americanpharmaceuticalreview
February 22, 2021
Xeris Pharmaceuticals announced the European Commission (EC) has approved Ogluo™ (glucagon) injection for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
US FDA approves Amphastar’s generic drug to treat severe hypoglycemia pharmaceutical-business-review
January 06, 2021
The US Food and Drug Administration (FDA) has approved the first generic drug produced by Amphastar Pharmaceuticals to treat severe hypoglycemia.
New Continuous Glucose Monitor May Cut Hypoglycemia in T1DM drugs
January 06, 2020
Intermittently scanned continuous glucose monitoring (isCGM) results in higher treatment satisfaction among adults with type 1 diabetes, according to a study published online December in Diabetes Care.
Endocrine Society Releases Hypoglycemia Performance Measures drugs
December 25, 2019
A new set of quality measures can help health care providers identify older adults with type 2 diabetes who are at increased risk for hypoglycemia, according to an article published online in the Journal of Clinical Endocrinology & Metabolism.
FDA grants regulatory approval for hypoglycemia treatment europeanpharmaceuticalreview
September 16, 2019
GVOKE injection has received regulatory approval from the FDA for the treatment of severe hypoglycemia in patients with diabetes.
FDA Approves Gvoke (glucagon), the First Ready-to-use Stable Liquid Glucagon for Severe Hypoglycemia drugs
September 12, 2019
Xeris Pharmaceuticals, Inc. a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations...
Use of Pain Reliever Tramadol May Up Risk for Hypoglycemia drugs
September 10, 2019
Use of the widely prescribed opioid tramadol is associated with a greater risk for developing hypoglycemia compared with almost every other opioid, according to a study published online in Scientific Reports.
Hypoglycemia Up With Intensive Glucose-Lowering Therapy drugs
August 20, 2019
Intensive glucose-lowering therapy is prevalent among U.S. adults with diabetes and results in hospitalizations and emergency department visits for hypoglycemia...

Previous page 1 2 Next page